NCT06715163View on ClinicalTrials.gov

Evaluation of the Safety and Tolerability of Three Doses of Diamine Oxidase (DAO) in Healthy Volunteers

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

July 8, 2024

Primary Completion Date

July 29, 2024

Study Completion Date

July 29, 2024

Conditions
Safety and Tolerability in Healthy Volunteers
Interventions
DIETARY_SUPPLEMENT

Dose 1 (42mg) of DAO

DAO extract is obtained from pea sprout dehydrated powder. Lowest dose of DAO administered in this study

DIETARY_SUPPLEMENT

Placebo

Contains the same excipients as the DAO tablets but without the diamino oxidase content

DIETARY_SUPPLEMENT

Dose 2 (84mg) of DAO

DAO extract is obtained from pea sprout dehydrated powder. Medium dose of DAO administered in this study

DIETARY_SUPPLEMENT

Dose 3 (210mg) of DAO

DAO extract is obtained from pea sprout dehydrated powder. Highest dose of DAO administered in this study

Trial Locations (1)

08041

Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Barcelona

Sponsors

Lead Sponsor

AB Biotek
All Listed Sponsors
collaborator

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

lead

AB Biotek

INDUSTRY